Breaking News Instant updates and real-time market news.

HDP

Hortonworks

$7.46

-1.24 (-14.25%)

, TLND

Talend

$22.22

-0.41 (-1.81%)

10:44
10/13/16
10/13
10:44
10/13/16
10:44

Goldman says sell Hortonworks, buy Talend as move to cloud accelerates

Goldman Sachs downgraded Hortonworks (HDP) to Sell from Buy and upgraded Talend (TLND) to Buy from Hold, citing the impact of the cloud's growth. TWO NOTCH DOWNGRADE: The transfer of analytics workloads to the cloud is beginning to significantly accelerate, and this development will probably increase competition in the space, harming Hortonworks, wrote Goldman analyst Jesse Hulsing. Moreover, the consensus billings outlook for the company implies that its employee productivity will increase significantly, but its productivity has been declining, and recent changes to its sales leadership could also hurt, Hulsing believes. If Hortonworks' billings come in below the consensus outlook, the company's multiple may continue to be pressured, and its attainment of break even free cash flow could be delayed, the analyst wrote. He slashed his price target on the shares to $7 from $13. TALEND: Talend is "uniquely" positioned to benefit from the faster than expected transfer of analytic workloads to the cloud, wrote Hulsing. The company's technology enables users to exploit commodity processing and elasticity, the analyst stated. Moreover, its pricing is not tied to the size of data workloads, making it appealing as workloads grow, Hulsing believes. Talend's stock has dropped 16% over the last month, partly due to the weakness of the British pound, and the decline has been overdone, according to the analyst. Hulsing says that Talend's subscription base can increase over 30% through fiscal 2018, while its free cash flow is positive and it's now undervalued versus its peers. He kept a $31 price target on the shares. PRICE ACTION: In early trading, Hortonworks dropped 4.75% to $7.11 and Talend jumped 9% to $24.21.

HDP

Hortonworks

$7.46

-1.24 (-14.25%)

TLND

Talend

$22.22

-0.41 (-1.81%)

  • 03

    Nov

  • 10

    Nov

  • 14

    Nov

HDP Hortonworks
$7.46

-1.24 (-14.25%)

08/05/16
NEED
08/05/16
DOWNGRADE
NEED
Hold
Hortonworks downgraded to Hold at Needham
As previously reported, Needham analyst Richard Kugele downgraded Hortonworks to Hold from Buy following a slight miss in Q2 and lower guidance. The analyst says he is "stepping aside" as the company works through its sales issues.
08/08/16
RSBL
08/08/16
INITIATION
Target $20
RSBL
Buy
Hortonworks initiated with a Buy at Rosenblatt
Rosenblatt analyst Marshall Senk initiated Hortonworks with a Buy and $20 price target saying the combination of high renewal rates and customer revenue growth will serve to drive the P&L toward profitability over the next few years.
09/30/16
COWN
09/30/16
NO CHANGE
COWN
Hortonworks checks 'concerning,' quarter at risk, says Cowen
Cowen analyst J. Derrick Wood said his checks suggest there have been many high-level employee departures at Hortonworks (HDP) and he also thinks that sales productivity is constrained, presenting risk to its quarterly results. Meanwhile, he said that his checks on Teradata (TDC) remain constructive, noting that he is hearing the company is already signing orders for cloud with its core analytical database products now available on AWS. There are "some encouraging data points" for Tableau (DATA), said Wood, who added that he still has more field work to do around its quarter.
10/13/16
GSCO
10/13/16
DOWNGRADE
Target $7
GSCO
Sell
Hortonworks downgraded to Sell from Buy at Goldman
Goldman analyst Jesse Hulsing downgraded Hortonworks two notches to Sell from Buy and lowered its price target to $7 from $13. The analyst his previous thesis of sustained growth from ongong Hadoop adoption and improved efficiency due to higher mix of expansions was wrong. He expects increased competition for new analytics workloads from cloud services vendors will challenge Hortonworks' pure open source business model and is concerned that FY17 Street billings estimates are too high.
TLND Talend
$22.22

-0.41 (-1.81%)

08/26/16
WBLR
08/26/16
NO CHANGE
WBLR
Outperform
Investor confusion responsible for Talend pullback, says William Blair
William Blair analyst Bhavan Suri believes Talend delivered "solid" results in its first report as a public company, noting that all its metrics came in ahead of the firm's expectations and above the high end of the preliminary ranges provided in the IPO process. However, Suri attributes the post-earnings pullback in the stock to possible confusion on share count and net income guidance, explaining that consensus mismodeled the company's IFRS share count for the quarter by almost 20M shares, which made its EPS appear to be below expectations even though its net income was above the firm's estimate and at the company's preliminary range. Suri keeps an Outperform rating on Talend, citing its "healthy" Big Data and Cloud momentum.
09/26/16
RSBL
09/26/16
INITIATION
Target $30
RSBL
Buy
Talend initiated with a Buy at Rosenblatt
Rosenblatt analyst Marshall Senk initiated Talend with a Buy and a $30 price target.
10/13/16
GSCO
10/13/16
UPGRADE
GSCO
Buy
Talend upgraded to Buy from Neutral at Goldman
Goldman analyst Jesse Hulsing upgraded Talend to Buy and maintained its $31 price target saying the company will benefit from analytic workloads moving to the cloud. Hulsing said Talend is well positioned to benefit from this trend given its technology approach that allows users to take advantage of commodity processing and elasticity and a pricing model that is not tied to core growth. The analyst views the recent share pullback as a buying opportunity for a company with 30%+ subscription growth.
10/13/16
10/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Buy from Neutral at BofA/Merrill with analyst Colin Bristow citing its opportunity in first line lung cancer. 2. Viacom (VIA, VIAB) upgraded to Market Perform from Underperform at Wells Fargo and to Buy from Underperform at BofA/Merrill. 3. TD Ameritrade (AMTD) and Charles Schwab (SCHW) were upgraded to Buy from Neutral at BofA/Merrill. 4. Talend (TLND) upgraded to Buy from Neutral at Goldman with analyst Jesse Hulsing saying the company will benefit from analytic workloads moving to the cloud. 5. CSC (CSC) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ZBRA

Zebra Technologies

$85.73

-0.95 (-1.10%)

06:33
02/23/17
02/23
06:33
02/23/17
06:33
Earnings
Zebra Technologies reports Q4 EPS $1.93, consensus $1.73 »

Reports Q4 revenue $942M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

WAAS

AquaVenture

$18.01

0.69 (3.98%)

06:33
02/23/17
02/23
06:33
02/23/17
06:33
Upgrade
AquaVenture rating change  »

AquaVenture upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

SAGE

SAGE Therapeutics

$61.93

-2.13 (-3.33%)

06:32
02/23/17
02/23
06:32
02/23/17
06:32
Hot Stocks
Breaking Hot Stocks news story on SAGE Therapeutics »

SAGE Therapeutics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SAGE

SAGE Therapeutics

$61.93

-2.13 (-3.33%)

06:31
02/23/17
02/23
06:31
02/23/17
06:31
Earnings
Breaking Earnings news story on SAGE Therapeutics »

SAGE Therapeutics reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LB

Labarge

$58.13

0.43 (0.75%)

06:31
02/23/17
02/23
06:31
02/23/17
06:31
Recommendations
Labarge analyst commentary  »

L Brands selloff brings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GE

General Electric

$30.09

-0.19 (-0.63%)

06:30
02/23/17
02/23
06:30
02/23/17
06:30
Periodicals
Suez in the running for General Electric's water unit, Reuters reports »

France's Suez is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

DLHC

DLH Holdings Corp.

$5.27

-0.08 (-1.50%)

06:30
02/23/17
02/23
06:30
02/23/17
06:30
Initiation
DLH Holdings Corp. initiated  »

DLH Holdings Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CM

CIBC

$89.90

0.44 (0.49%)

06:28
02/23/17
02/23
06:28
02/23/17
06:28
Earnings
CIBC reports Q1 adjusted EPS C$2.89, consensus C$1.96 »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMRE

Global Medical REIT

$8.48

0.06 (0.71%)

06:28
02/23/17
02/23
06:28
02/23/17
06:28
Initiation
Global Medical REIT initiated  »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$184.01

-0.51 (-0.28%)

06:25
02/23/17
02/23
06:25
02/23/17
06:25
Hot Stocks
Teleflex CEO Benson Smith retiring at end of 2017, succeeded by COO Liam Kelly »

Teleflex CEO Benson Smith…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

MBLY

Mobileye

$47.42

1.3 (2.82%)

06:22
02/23/17
02/23
06:22
02/23/17
06:22
Recommendations
Mobileye analyst commentary  »

Mobileye price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRI

Carter's

$83.58

-0.4 (-0.48%)

06:20
02/23/17
02/23
06:20
02/23/17
06:20
Hot Stocks
Carter's raises quarterly dividend 12% to 37c per share »

For payment on March 24…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CRI

Carter's

$83.58

-0.4 (-0.48%)

06:19
02/23/17
02/23
06:19
02/23/17
06:19
Earnings
Carter's sees FY17 adjusted EPS growth 8%-10%, consensus $5.52 »

For fiscal 2017, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CRI

Carter's

$83.58

-0.4 (-0.48%)

06:18
02/23/17
02/23
06:18
02/23/17
06:18
Earnings
Carter's sees Q1 adjusted EPS 80c-85c, consensus $1.14 »

For the first quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

NVCR

Novocure

$7.15

-0.15 (-2.05%)

06:17
02/23/17
02/23
06:17
02/23/17
06:17
Hot Stocks
Novocure Chief Commercial Officer Peter Melnyk departing »

Novocure's Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 02

    Mar

CS

Credit Suisse

$15.35

-0.13 (-0.84%)

06:17
02/23/17
02/23
06:17
02/23/17
06:17
Periodicals
Credit Suisse allocates $600M to expand Saudi Arabia business, Bloomberg says »

Credit Suisse is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

OUT

OUTFRONT Media

$26.89

-0.44 (-1.61%)

06:16
02/23/17
02/23
06:16
02/23/17
06:16
Downgrade
OUTFRONT Media rating change  »

OUTFRONT Media downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CRI

Carter's

$83.58

-0.4 (-0.48%)

06:16
02/23/17
02/23
06:16
02/23/17
06:16
Hot Stocks
Breaking Hot Stocks news story on Carter's »

Carter's raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

EFOI

Energy Focus

$3.71

-0.21 (-5.36%)

06:16
02/23/17
02/23
06:16
02/23/17
06:16
Hot Stocks
Energy Focus sees Q1 restructuring charges of $1.1M »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CRI

Carter's

$83.58

-0.4 (-0.48%)

06:16
02/23/17
02/23
06:16
02/23/17
06:16
Earnings
Carter's reports Q4 adjusted EPS $1.79, consensus $1.67 »

Reports Q4 revenue $934M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CMVT

Comverse

06:15
02/23/17
02/23
06:15
02/23/17
06:15
Periodicals
Former Comverse CEO faces sentencing in fraud case, Reuters reports »

Jacob "Kobi"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFOI

Energy Focus

$3.71

-0.21 (-5.36%)

06:15
02/23/17
02/23
06:15
02/23/17
06:15
Recommendations
Energy Focus analyst commentary  »

Energy Focus reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BAYRY

Bayer

$113.85

-1.15 (-1.00%)

, MON

Monsanto

$111.38

0.81 (0.73%)

06:13
02/23/17
02/23
06:13
02/23/17
06:13
Periodicals
Bayer looks to raise $19B in equity to fund proposed Monsanto deal, WSJ reports »

Bayer (BAYRY) is looking…

BAYRY

Bayer

$113.85

-1.15 (-1.00%)

MON

Monsanto

$111.38

0.81 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

  • 01

    Apr

  • 26

    Jun

IRM

Iron Mountain

$37.14

-0.57 (-1.51%)

06:13
02/23/17
02/23
06:13
02/23/17
06:13
Earnings
Iron Mountain sees FY17 revenue growth 8%-10%, consensus $3.8B »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 01

    Mar

  • 20

    Apr

TSLA

Tesla

$273.51

-3.88 (-1.40%)

06:12
02/23/17
02/23
06:12
02/23/17
06:12
Recommendations
Tesla analyst commentary  »

JPMorgan sees another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.